<div class="""t"" m0="" x0="" h9="" y15="" ff6="" fs4="" fc1="" sc0="" ls5="" ws36"="" style="position: absolute; white-space: pre; font-size: 37.2px; transform-origin: 0px 100%; unicode-bidi: bidi-override; font-family: ff6; line-height: 1.349; visibility: visible; transform: matrix(0.400327, 0, 0, 0.400327, 0, 0); text-shadow: none; -webkit-text-stroke: 0.015em transparent; word-spacing: -8.4444px; color: rgb(0, 0, 0); bottom: 527.646px; height: 36.7908px; left: 68.0556px;">
EMI1, while potently reducing the interaction of EGFR
triple mutant with Shc1 in our MaMTH-DS assay, did not behave
as a TKI and displayed no inhibition of the kinase activity of EGFR
triple-mutant protein invitro
EMI1, while potently reducing the interaction of EGFR
triple mutant with Shc1 in our MaMTH-DS assay, did not behave
as a TKI and displayed no inhibition of the kinase activity of EGFR
triple-mutant protein invitro
triple mutant with Shc1 in our MaMTH-DS assay, did not behave
as a TKI and displayed no inhibition of the kinase activity of EGFR
triple-mutant protein invitro |
